SCHEMBL19782074

SCHEMBL19782074

CONC(=O)Nc1c(C)cccc1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.49
ALDH1A1 P00352 3/20 0.47
DRD2 P14416 1/20 0.46
HTR2A P28223 1/20 0.46
HTR2B P41595 1/20 0.46
KMT2A Q03164 2/20 0.46
PKM P14618 1/20 0.45
POLB P06746 1/20 0.44
RAB9A P51151 2/20 0.43
PDE4D Q08499 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
NLRP3 Q96P20 1/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 1/20 0.42
ALOX15 P16050 1/20 0.42
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19781758 0.81 NLRP3 (0.53) ATMALDH1A1KMT2APDE4DNLRP3
SCHEMBL23491343 0.81 CACNA1C (0.48) ALDH1A1KMT2APKMRAB9APDE4D
SCHEMBL22096841 0.80 ALDH1A1 (0.43) ALDH1A1KMT2APKMRAB9APDE4D
SCHEMBL19779545 0.80 LPAR1 (0.53) ALDH1A1KMT2ALMNA
SCHEMBL18955464 0.79 ALDH1A1 (0.55) ALDH1A1KMT2APOLBRAB9ANLRP3
SCHEMBL11054313 0.78 DRD2 (0.55) ATMALDH1A1DRD2HTR2AHTR2B
SCHEMBL3598057 0.78 ALDH1A1 (0.50) ALDH1A1KMT2APKMPOLBNLRP3
SCHEMBL20194482 0.78 ALDH1A1 (0.53) ALDH1A1KMT2APOLBRAB9ANLRP3
SCHEMBL19779362 0.77 RAPGEF4 (0.42) ALDH1A1KMT2ARAB9ACA12CA1
SCHEMBL28921103 0.77 ALDH1A1 (0.49) ALDH1A1DRD2HTR2AHTR2BKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210171492-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2021-06-10 US disclosed
US-10597377-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2020-03-24 US disclosed
US-10351547-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2019-07-16 US disclosed
US-20190002431-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2019-01-03 US disclosed
US-9896432-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2018-02-20 US disclosed
WO-2018013676-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10597377-B2 Somatostatin modulators and uses thereof SSTR5, SSTR2, SSTR4 ATM 3578/4885ALDH1A1 4626/4885DRD2 2265/4885
US-10351547-B2 Somatostatin modulators and uses thereof SSTR5, SSTR2, SSTR4 ATM 3578/4885ALDH1A1 4626/4885DRD2 2265/4885
US-20190002431-A1 SOMATOSTATIN MODULATORS AND USES THEREOF SSTR5, SSTR2, SSTR4 ATM 3578/4885ALDH1A1 4626/4885DRD2 2265/4885
US-20210171492-A1 SOMATOSTATIN MODULATORS AND USES THEREOF SSTR5, SSTR2, SSTR4 ATM 3578/4885ALDH1A1 4626/4885DRD2 2265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.